Skip to main content
Log in

Amikacin/ceftolozane/tazobactam/gentamicin

Drug resistance and lack of efficacy: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Borghesi L, et al. Successful prolonged cefiderocol treatment of a chronic left pleural empyema caused by Pseudomonas aeruginosa in a patient affected by COVID-19: a case report. Journal of Global Antimicrobial Resistance 27: 157-159, Dec 2021. Available from: URL: http://doi.org/10.1016/j.jgar.2021.09.005

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Amikacin/ceftolozane/tazobactam/gentamicin. Reactions Weekly 1911, 25 (2022). https://doi.org/10.1007/s40278-022-17322-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-17322-x

Navigation